What You Need To Know About Infectious Disease
Prevention & Treatment
International Cooperation
National borders are trivial impediments to infectious disease threats. In the highly interconnected and readily traversed global village of our time, one nation’s problem soon becomes every nation’s problem. Therefore, strategies must be implemented worldwide, not just nationally, in order to have a true impact.
Explore Other Topics
What do you know about infectious disease?
If you have strep throat, which of the following forms of medication can be used to effectively treat the infection?
-
Sorry, that’s incorrect.
Because strep throat is caused by a bacterium called Streptococcus pyogenes, it is treatable with antibiotics but not antivirals. Currently there is no vaccine available to prevent strep throat.
-
Correct!
Because strep throat is caused by a bacterium called Streptococcus pyogenes, it is treatable with antibiotics but not antivirals. Currently there is no vaccine available to prevent strep throat.
-
Sorry, that’s incorrect.
Because strep throat is caused by a bacterium called Streptococcus pyogenes, it is treatable with antibiotics but not antivirals. Currently there is no vaccine available to prevent strep throat.
-
Sorry, that’s incorrect.
Because strep throat is caused by a bacterium called Streptococcus pyogenes, it is treatable with antibiotics but not antivirals. Currently there is no vaccine available to prevent strep throat.
Infectious Disease Defined
- Fertilized Egg
Sometimes referred to as a zygote, this is the resulting initial cell formed when a sperm cell unites with an egg cell.
National Academies
Search the National Academies Press website by selecting one of these related terms.
Source Material
- Infectious Disease Movement in a Borderless World—Workshop Summary (2010)
- Global Issues in Water, Sanitation, and Health—Workshop Summary (2009)
- Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases (2009)
- The U.S. Commitment to Global Health: Recommendations for the Public and Private Sectors (2009)
- Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin—Workshop Summary (2008)
- Global Infectious Disease Surveillance and Detection: Assessing the Challenges, Finding Solutions—Workshop Summary (2007)
- Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance (2004)
